Inhibition of phosphoinositide 3-kinase related kinases by the radiosensitizing agent wortmannin.

Members of the phosphatidylinositol-3 kinase related kinase (PIKK) family function in both cell cycle progression and DNA damage-induced cell cycle checkpoints. The fungal metabolite, wortmannin, is an effective radiosensitizer that irreversibly inhibits certain members of the PIKK family. Based on their roles in DNA damage responses, several PIKKs, DNA-dependent protein kinase (DNA-PK), ataxia telangiectasia mutated (ATM) and the ataxia- and Rad3-related protein (ATR), are potential targets for the radiosensitizing effect of wortmannin. In this report, we demonstrate that wortmannin is a relatively potent inhibitor of DNA-PK (IC50, 16 nM) and ATM (IC50, 150 nM) activities, whereas ATR activity is significantly less sensitive to this drug (IC50, 1.8 microM). In intact A549 lung adenocarcinoma cells, wortmannin inhibited both DNA-PK and ATM at concentrations that correlated closely with those required for radiosensitization. Furthermore, pretreatment of A549 cells with wortmannin resulted in radioresistant DNA synthesis, a characteristic abnormality of ATM-deficient cells. These results identify wortmannin as an inhibitor of ATM activity and suggest that ATM and DNA-PK are relevant targets for the radiosensitizing effect of this drug in cancer cells.

[1]  S. Schreiber,et al.  Overexpression of a kinase‐inactive ATR protein causes sensitivity to DNA‐damaging agents and defects in cell cycle checkpoints , 1998, The EMBO journal.

[2]  Christine C. Hudson,et al.  Phosphorylation of the translational repressor PHAS-I by the mammalian target of rapamycin. , 1997, Science.

[3]  K. Rosenzweig,et al.  Radiosensitization of human tumor cells by the phosphatidylinositol3-kinase inhibitors wortmannin and LY294002 correlates with inhibition of DNA-dependent protein kinase and prolonged G2-M delay. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[4]  T. Haystead,et al.  Identification of Phosphorylation Sites in the Translational Regulator, PHAS-I, That Are Controlled by Insulin and Rapamycin in Rat Adipocytes* , 1997, The Journal of Biological Chemistry.

[5]  J. Allalunis-Turner,et al.  Intact G2-phase checkpoint in cells of a human cell line lacking DNA-dependent protein kinase activity. , 1997, Radiation research.

[6]  M. Kastan,et al.  p53 and ATM: cell cycle, cell death, and cancer. , 1997, Advances in cancer research.

[7]  S. Boulton,et al.  Wortmannin is a potent inhibitor of DNA double strand break but not single strand break repair in Chinese hamster ovary cells. , 1996, Carcinogenesis.

[8]  M. Zvelebil,et al.  Wortmannin inactivates phosphoinositide 3-kinase by covalent modification of Lys-802, a residue involved in the phosphate transfer reaction , 1996, Molecular and cellular biology.

[9]  B. Price,et al.  The phosphatidylinositol 3-kinase inhibitor wortmannin sensitizes murine fibroblasts and human tumor cells to radiation and blocks induction of p53 following DNA damage. , 1996, Cancer research.

[10]  T. Jorgensen,et al.  The ATM gene and the radiobiology of ataxia-telangiectasia. , 1996, International journal of radiation biology.

[11]  S. Schreiber,et al.  PIK-Related Kinases: DNA Repair, Recombination, and Cell Cycle Checkpoints , 1995, Science.

[12]  M. Connelly,et al.  DNA-dependent protein kinase catalytic subunit: A relative of phosphatidylinositol 3-kinase and the ataxia telangiectasia gene product , 1995, Cell.

[13]  L. A. Burns,et al.  Interleukin-2 triggers a novel phosphatidylinositol 3-kinase-dependent MEK activation pathway , 1995, Molecular and cellular biology.

[14]  J. Dodge,et al.  Wortmannin, a potent and selective inhibitor of phosphatidylinositol-3-kinase. , 1994, Cancer research.

[15]  M. Lavin,et al.  Radiosensitivity in ataxia-telangiectasia: anomalies in radiation-induced cell cycle delay. , 1994, International journal of radiation biology.

[16]  Andrew J. Bannister,et al.  c-Jun is phosphorylated by the DNA-dependent protein kinase in vitro; definition of the minimal kinase recognition motif. , 1993, Nucleic acids research.

[17]  R. Abraham,et al.  Rapamycin-induced inhibition of p34cdc2 kinase activation is associated with G1/S-phase growth arrest in T lymphocytes. , 1993, The Journal of biological chemistry.

[18]  Y. Okumura,et al.  Murine scid cells complement ataxia-telangiectasia cells and show a normal post-irradiation response of DNA synthesis. , 1993, International journal of radiation biology.

[19]  K. Sakaguchi,et al.  Human DNA-activated protein kinase phosphorylates serines 15 and 37 in the amino-terminal transactivation domain of human p53 , 1992, Molecular and cellular biology.

[20]  T. McMillan,et al.  The nature of the initial slope of radiation cell survival curves. , 1992, BJR supplement.

[21]  G. Steel,et al.  Modification of radiation dose-rate sparing effects in a human carcinoma of the cervix cell line by inhibitors of DNA repair. , 1988, International journal of radiation biology.

[22]  Fowler Jf.  The first James Kirk memorial lecture. What next in fractionated radiotherapy? , 1984, The British journal of cancer. Supplement.

[23]  R. Fawcitt.  The nature of the initial slope of radiation cell survival curves. , 1951 .